Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Valeant
Valeant
Page 2 of 12
Finance
L’Oreal Is Snapping Up These 3 Brands from Valeant for $1.3 Billion
By
Reuters
and
Michelle Toh
January 10, 2017
Finance
These Are the 7 Biggest Hedge Fund Disasters of 2016
By
Market Analyst
December 27, 2016
Leadership
Bill Ackman Says Valeant Might Change Its Name to Fix Its Reputation
By
Industry Analyst
November 11, 2016
Health
Valeant Has Been Subpoenaed Over Its Pharmacy Activities
By
Staff Writer
November 10, 2016
Finance
Why Valeant Can’t “Dig Out of That Hole” Fast Enough
By
Industry Analyst
November 8, 2016
Finance
Valeant Shares Flop After Reporting Smaller-Than-Expected Profits
By
Industry Analyst
November 8, 2016
Health
Valeant Is Being Sued Over the ‘Female Viagra’ Pill
By
Reuters
and
Tekendra Parmar
November 3, 2016
Finance
Here’s Why Valeant Selling Salix Was a Huge Surprise to the Stock Market
By
Senior Editor
November 2, 2016
Finance
Here’s Why Valeant’s Shares Just Plunged, Again
By
Blockchain Reporter
October 31, 2016
Health
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
By
Financial Writer
October 17, 2016
Health
Allergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By
Trading Desk
September 6, 2016
Finance
Bill Ackman’s Hedge Fund Is Making Money Again on Valeant’s Rebound
By
Editorial Team
September 2, 2016
Finance
What Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By
Industry Analyst
August 25, 2016
Finance
Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO
By
Reuters
and
Michelle Toh
August 22, 2016
Health
Valeant’s Female Libido Pill Just Got Some Really Low Ratings
By
Ed Silverman
and
STAT News
August 18, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Trading Desk
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Editorial Team
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Staff Writer